Skip to main content

Table 1 Comparison between the studied groups according to demographic data

From: Klebsiella infections in a pediatric intensive care unit: incidence, antimicrobial susceptibility, and resistance genes

Demographic data

Total (n =44)

Outcome

p

Discharged (n = 27)

Deceased (n =17)

Sex n (%)

 Male

23 (52.3%)

13 (48.1%)

10 (58.8%)

0.490

 Female

21 (47.7%)

14 (51.9%)

7 (41.2%)

Age (months) n (%)

 <12

33 (75.0%)

21 (77.8%)

12 (70.6%)

MCp=0.648

 12–60

8 (18.2%)

5 (18.5%)

3 (17.6%)

 >60

3 (6.8%)

1 (3.7%)

2 (11.8%)

PIM2

 Min.–Max.

2.0–100.0

2.0–72.50

9.0–100.0

0.037*

 Mean ± SD.

39.4 ± 26.6

32.0 ± 22.0

51.1 ± 29.6

 Median (IQR)

34.0 (20–56.87)

25.6 (18.25–55.7)

49.0 (32–71.50)

LOS (weeks)

 Min.–Max.

0.14–12.0

1.14–12.0

0.14–4.0

<0.001*

 Mean ± SD.

2.60 ± 2.33

3.42 ± 2.49

1.31 ± 1.27

 Median (IQR)

2.0 (1.07–4.0)

3.0 (2.0–4.0)

0.71 (0.43–2.0)

PELOD

 Min.–Max.

6.0–30.0

6.0–21.0

16.0–30.0

<0.001*

 Mean ± SD.

17.16 ± 5.87

13.93 ± 4.28

22.29 ± 4.15

 Median (IQR)

17 (14.0–21.5)

14.0 (11–16.5)

22 (18.0–24.0)

Resistance

 MDR

37 (84.1%)

26 (96.3%)

11 (64.7%)

0.009*

 XDR

7 (15.9%)

1 (3.7%)

6 (35.3%)

 PDR

0 (0.0%)

0 (0.0%)

0 (0.0%)

  1. PIM2 pediatric index of mortality 2, LOS length of stay, PELOD pediatric logistic organ dysfunction, MDR multidrug-resistant, XDR extensive drug-resistant, PDR pan-drug-resistant
  2. * p value significant